Article
Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) - 1 Jul 2022
Uezato Akihito, Jitoku Daisuke, Shimazu Dai, Yamamoto Naoki, Kurumaji Akeo, Iwayama Yoshimi, Toyota Tomoko, Yoshikawa Takeo, Haroutunian Vahram, Bentea Eduard, Meller Jarek, Sullivan Courtney R, Meador-Woodruff James H, McCullumsmith Robert E, Nishikawa Toru
Abstract excerpt
Lithium's inhibitory effect on enzymes involved in sulfation process, such as inhibition of 3'(2')-phosphoadenosine 5'-phosphate (PAP) phosphatase, is a possible mechanism of its therapeutic effect for bipolar disorder (BD). 3'-Phosphoadenosine 5'-phosphosulfate (PAPS) is translocated from cytosol to Golgi lumen by PAPS transporter 1 (PAPST1/SLC35B2), where it acts as a sulfa donor. Since SLC35B2 was previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
